Bainbridge Island, United States
Solius Labs, founded in 2011, offers cutting-edge solutions in the Biotechnology and Health Care sectors. Their product, SOLIUS® Medical Light Therapy, distinguishes itself by leveraging specific wavelengths of sunlight to enhance human health, emphasizing the production of Vitamin D while minimizing sun exposure risks. This approach taps into the natural healing capabilities of the body, marking a step forward in Health and Wellness with implications for Medical Devices.
The company is based in the United States and showcases its potential in a rapidly growing market. The most recent funding round, a Series B investment completed on 13 May 2020, was backed by Human Longevity, reflecting investor confidence in its innovative approach and market viability. Solius Labs offers a unique value proposition through its proprietary technology, serving as a compelling opportunity for investors interested in transformative health solutions.
